1 min read
SCOPE: Powering the Future of Clinical Research
Meet Veristat at SCOPE: Powering the Future of Clinical Research February 2-5, 2026
🔬 Advancing Clinical Research with...
Current advances in RNA-based therapies hold substantial promise in treating and preventing many human diseases and disorders through curing the disease, rather than treating the symptomology like traditional therapeutics.
While many RNA therapeutics have made it to clinical trials, only a few have been approved. Veristat’s team of scientific-minded experts
have worked on over 60 RNA programs, including several approved
therapies. Our experience expands across the clinical development pathway in a broad range of therapeutic areas.
Meet Veristat. Learn More.
1 min read
Nov 20, 2025 Veristat Events
🔬 Advancing Clinical Research with...
1 min read
Oct 22, 2025 Veristat Events
Veristat is excited to attend the ASH Annual Meeting and...